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The authors wish to correct an inaccurate statement made in the Experimental Procedures on the concentration of the drug tPA
(p. 668).
The following sentence appeared in the published article:
Mice were injected with human recombinant tPA (kindly provided by Eisai, Tokyo, Japan) intraperitoneally at a concentration of 1.253
106 IU = 1 mg/kg body weight daily or PBS for a total of 3 days. (Recommended tPA dosage in humans for clinical use is 10 mg/kg.)
The corrected passage is printed below:
Mice were injected with human recombinant tPA (kindly provided by Eisai, Tokyo, Japan) intraperitoneally at a concentration of 1.253
106 IU = 10 mg/kg body weight daily or PBS for a total of 3 days. (Recommended tPA dosage in humans for clinical use is 10 mg/kg.)
The authors deeply regret the error.120 Cell Stem Cell 3, 119–120, July 2008 ª2008 Elsevier Inc.
